For Sanofi SA (ADR) (SNY) Chronic Diseases Present the Future Focus

In an interview with CNBC, Chris Viehbacher, the CEO of Sanofi SA (ADR) (NYSE:SNY), discussed the steps that big pharma companies like Sanofi SA (ADR) (NYSE:SNY) are taking to tackle chronic diseases that are a major cause of worry for the aging baby boomers who are heading towards retirement age.

Sanofi SA (ADR) (NYSE:SNY)

Speaking on the growing problem of chronic disease among elderly, Viehbacher said that the chronic disease like Type II diabetes, cardiovascular disease are commonly seen among elderly and over 50% of people over the age of 60 have a chronic disease.

“There’s basically three ways I think we have to go about it. First is, I think we have to start earlier in life. We have to do a much better job in our health care systems of preventing chronic diseases, a lot of them. With some diet and exercise, you can avoid diseases in cardiovascular and diabetes. The second is, you know we have to yet make it a lot easier for people to take their medicines, and really get to better outcomes, and the third is clearly what we all in our industry see as our mission and that is to develop new medicines.”

According to Viehbacher, Pharma companies like Sanofi SA (ADR) (NYSE:SNY) need to continue with innovation and even though some diseases like Alzheimer’s cannot be treated, it is essential that companies develop better medicines for those chronic diseases which can be treated.

Viehbacher also said that it is necessary for people to make changes to their modern lifestyles and adopt practices like being aware of one’s nutritional needs, physical activity needs, etc. The head of Sanofi SA (ADR) (NYSE:SNY) is a chairman of a CEO roundtable on cancer which engages employers to introduce preventive care in the workplace, and he feels that more such initiatives are the need of the hour.

Commenting on the future of medicines for chronic diseases, Viehbacher said:

“One of the interesting things we are seeing is some really interesting new medicines coming along in the whole industry really. I think ten years ago we all understood that we couldn’t bring me-too products to market anymore and so we all really invested in some disruptive innovation. I think you are going to see a number of new medicines coming along that have revolutionary levels of efficacy.”

Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!